The Need is Critical
In preparation for a fundraiser tomorrow (Thank you Ashley!), I revisited some of the information that I was given at the beginning of this endeavor. This is why I am running 26.2 miles.
Leukemia, lymphoma and myeloma are cancers that originate in the bone marrow or lymphatic tissue as the result of an acquired genetic injury to the DNA of a single cell. The cell then becomes malignant and multiplies continuously. This abnormal accumulation interferes with the production of healthy blood cells. An estimated 823,349 Americans are living with blood cancers. Every 5 minutes someone new is diagnosed with a blood cancer. Every 10 minutes someone dies.
LEUKEMIA
- In the United States, 218,659 people are living with or in remission from leukemia.
- Leukemia causes more deaths than any other cancer among children and young adults under the age of 20.
- The relative five-year survival rate for patients with leukemia has more than tripled in the past 46 years.
LYMPHOMA
- There are 544,266 people today living with lymphoma: 138,313 have or are in remission from Hodgkin lymphoma; 405,953 have or are in remission from Non-Hodgkin lymphoma (NHL).
- Non-Hodgkin Lymphoma is the fifth most common cancer in the United States, and its age-adjusted incidence rose by nearly 84 percent from 1975 - 2004.
- The five-year survival rate for patients with Hodgkin lymphoma rose from 73 percent in 1975 to 86 percent in 2004.
- The five-year survival rate for NHL patients rose from 48 percent in 1975 to 64 percent in 2003.
MYELOMA
- In 2007, 19,900 new case of myeloma will be diagnosed in the United States.
- Overall five-year survival has shown significant improvement since the 1960s, but was still only 34 percent in 2003.
THE LEUKEMIA & LYMPHOMA SOCIETY
The Leukemia & Lymphoma Society is the world’s largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. Founded in 1949, we are relentless in pursuit of our mission:
Cure Leukemia, Lymphoma, Hodgkin’s disease and Myeloma, and improve the quality of life of patients and their families.
The Society has invested more than $550 million in research since its inception in 1949, $61.6 million in fiscal year 2006 alone. Research funded by the Society has led or contributed to advances such as chemotherapy, bone marrow and stem cell transplantation, and new, targeted therapies that kill cancer cells without harming normal ones.
The Society also provides education for patients, families, and medical professionals; support groups for patients, families, and friends; and patient financial aid to help cover qualifying expenses, like prescription co-pays and transportation to treatment.
Thank you so much to all of my friends and family who have already donated. I don’t think that you can really even fully grasp the difference that your money has and will make.

